<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04786054</url>
  </required_header>
  <id_info>
    <org_study_id>BEDCAI37628</org_study_id>
    <nct_id>NCT04786054</nct_id>
  </id_info>
  <brief_title>Genetic Association of Glucocorticoid Receptor Gene Polymorphisms With Binge Eating</brief_title>
  <official_title>Genetic Association of Glucocorticoid Receptor Gene Polymorphisms With Binge Eating Disorders in Type 2 Diabetic Obese Female Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study was to specifically screen obese diabetic adolescent female&#xD;
      individuals for BED, checking the variants of the GR gene (rs56149945; rs41423247) amongst&#xD;
      identified individuals, and this led to assessing the impact of binge eating disorders on&#xD;
      glycaemic control in obese diabetic adolescent females in Pakistan, South Asia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Challenges in eating for diabetic adolescents can be categorized as eating disorders (ED) and&#xD;
      disordered eating symptoms (DES). Binge-eating disorder (BED) is defined as recurrent&#xD;
      episodes of binge eating at least once a week over a three-month time period and it is&#xD;
      accompanied by feeling the lack of control and marked distress over one's eating behaviour.&#xD;
      The aim of the present study was to specifically screen obese diabetic adolescent female&#xD;
      individuals for BED, checking the variants of the GR gene (rs56149945; rs41423247) amongst&#xD;
      identified individuals, and this led to assessing the impact of binge eating disorders on&#xD;
      glycaemic control in obese diabetic adolescent females in Pakistan, South Asia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">February 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BED</measure>
    <time_frame>Baseline</time_frame>
    <description>Presence of BED detected by individuals who score high on the BEDS7 Questionnaire administered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NR3C1 Presence of variants of the GR gene (rs56149945; rs41423247)</measure>
    <time_frame>Six months into the study after identifying all individuals who scored high on the BEDS7 Questionnaire</time_frame>
    <description>Presence of variants of the GR gene (rs56149945; rs41423247)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Binge-Eating Disorder</condition>
  <condition>Eating Disorders</condition>
  <condition>Obesity</condition>
  <condition>Diabetes Type 2</condition>
  <condition>Adolescent Behavior</condition>
  <arm_group>
    <arm_group_label>Group BED</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Those who are diagnosed with having Binge Eating disorder. These individuals qualified after the questionnaire was administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Non-BED</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Those who are not diagnosed with having Binge Eating disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>BED Questionnaire</intervention_name>
    <description>BED Questionnaire</description>
    <arm_group_label>Group BED</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Unmarried females diagnosed with Type 2 diabetes &gt; 12 months&#xD;
&#xD;
          -  Age 10-19 years&#xD;
&#xD;
          -  Obesity class I and II (based on BMI range of 30 - 40).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of psychosis, major psychiatric or neurocognitive disorder&#xD;
&#xD;
          -  Substance use&#xD;
&#xD;
          -  Untreated attention-deficit hyperactivity disorder&#xD;
&#xD;
          -  Use of psychopharmacological medications or psychotherapy&#xD;
&#xD;
          -  Class III obesity&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Biological female</gender_description>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zainab Khan</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2021</study_first_posted>
  <last_update_submitted>March 7, 2021</last_update_submitted>
  <last_update_submitted_qc>March 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Dr Zainab Khan</investigator_full_name>
    <investigator_title>Chief Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Bulimia</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Binge-Eating Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

